March 17th, 2010 by
Starlix, Diovan Not Effective in High-Risk Patients: Study

In a new study, the diabetes drug Starlix and the blood pressure med Diovan were not effective at reducing serious cardiac events in people at high risk for diabetes and heart disease, though Diovan did slow the progression of diabetes by 14 percent.

Read More…

March 17th, 2010 by
New Pelvic Artery Stent Approved

The U.S. Food and Drug Administration has approved Boston Scientific’s Express LD Iliac Stent to treat iliac artery disease, a condition characterized by blockages in the pelvic arteries that provide blood to the legs.

Read More…

March 17th, 2010 by
Aspirin Alone Effective for Preventing Clots a Year After Stenting

Researchers have found that patients who have a stent implanted and who take aspirin alone to prevent clots have the same rates of heart attack and death as people who are given both aspirin and the blood thinner Plavix.

Read More…

March 15th, 2010 by
High Natural Estrogen Boosts Women’s Stroke Risk: Study

A new study published in the journal Archives of Neurology has found that higher levels of naturally occurring estrogen are linked to an increased risk of stroke in postmenopausal women who are not taking hormone replacement therapy.

Read More…

March 15th, 2010 by
Intense Cholesterol, Blood Pressure Therapy No Help to Type 2 Diabetics: Study

Results from a new U.S. government-sponsored study show that aggressive cholesterol and blood pressure treatments do not reduce the risk of cardiac events in people with Type 2 diabetes. 

Read More…

March 14th, 2010 by
Flexible Work Schedule Boosts Physical, Mental Health: Study

A review of 10 previously published studies has found that people who have some control of their work schedules have better mental and physical health than people who work a set schedule.

Read More…

March 14th, 2010 by
Medication Fears Worsen Side Effects

According to a new study, patients who are worried about their medicines are more likely to suffer side effects from them.

Read More…

March 11th, 2010 by
Stroke Drug Combo Increases Bleeding Risk

Researchers are reporting that people who are given the clot-busting drug tPA after having a stroke caused by a blocked brain artery have a 10-fold risk of excessive bleeding if they’ve been taking the stroke drug Coumadin (warfarin).

Read More…

March 11th, 2010 by
Coffee May Lower Stroke Risk

A study of 23,000 adults has found that regular coffee drinking appears to reduce the risk of stroke.

Read More…

March 11th, 2010 by
Anti-Clotting Drug More Critical for Female Stroke Victims: Study

A new study published in the journal Neurology suggests that women who aren’t given the anti-clotting medication tissue plasminogen activator (tPA) fare worse than men who don’t receive the drug.

Read More…